Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 329
Immune Disorders Drugs 213
Biopharmaceuticals 189
Musculoskeletal Disorders Drugs 126
Genomics 123
Drug Discovery 122
Cardiovascular Drugs 109
Biotechnology 79
Clinical Trials 79
Biosimilars and Biosuperiors 77
Pharmaceuticals 75
Endocrine and Metabolic Disorders Drugs 71
Leukemia Drugs 70
Infusions and Injectables 65
Hematological Drugs 65
Dermatological Drugs 54
Women's Health 51
Central Nervous System Drugs 49
Liver and Kidney Disorders Drugs 48
Allergy and Immunology 47
Needles and Syringes 47
Diagnostics 42
Skin Cancer Drugs 38
Drug Delivery 35
Psoriasis Drugs 35
Colon Cancer Drugs 34
Oncology 33
Gastrointestinal Drugs 31
Infectious Diseases Drugs 29
Proteomics 29
Immunosuppressive Drugs 27
Hematology 26
Pharmaceutical Manufacturing 26
Brain Cancer Drugs 25
Analgesics 25
Enzymes 25
Lung Cancer Drugs 23
Lymphoma Drugs 22
Respiratory Drugs 22
Kidney Cancer Drugs 18
Therapeutic Area 15
Drugs by Therapeutic Area 15
Optical 15
Pancreatic Cancer Drugs 15
Optical Disorders Drugs 14
Healthcare Services 14
Nanomedicine 13
Ovarian Cancer Drugs 12
Dermatology 12
Sexual and Reproductive Health Drugs 12
E-Healthcare 11
Generic Drugs 11
Urology and Nephrology 10
Prostate Cancer Drugs 10
Cervical Cancer Drugs 10
Other Healthcare Facilities 10
Liver Cancer Drugs 9
Breast Cancer Drugs 9
In Vitro Diagnostics 9
Cardiology 9
Pulmonary Medicine 8
Vaccines 8
Cancer Vaccines 8
Asthma Drugs 8
Biomarkers 7
Company Reports 6
Medical Devices 6
Anti-Obesity Drugs 6
Gastroenterology 6
Managed Care 5
Biomaterials 5
Molecular Diagnostics 5
Mental Disorders Drugs 5
Animal Pharmaceuticals 4
Pharmaceutical Intermediates 4
Cardiovascular Devices 4
Thyroid Cancer Drugs 4
Laboratory Equipment 4
Pediatrics 4
Alzheimer's Disease Drugs 4
Diabetes Drugs 3
Bladder Cancer Drugs 3
Stem Cells 3
Surgical Procedures 3
Acne Drugs 3
Neurology 2
Pharmacoeconomics 2
Fertility Services 2
Orthopedic Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Over the Counter (OTC) Drugs 2
Uterine Cancer Drugs 2
Clinical Skills 2
Endocrinology 2
Schizophrenia Drugs 2
Patient Monitoring Equipment 1
Hepatology 1
Bioinformatics 1
Stents 1
Laboratory Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Diabetes Devices 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Nuclear Medicine and Radiopharmacology 1
Vitamins and Dietary Supplements 1
Clinical Therapies 1
Antibiotics 1
Palliative Care 1
Anatomy 1
Maternal and Neonatal Care 1
Allergy Drugs 1
Urological Disorders Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,101 Results (Page 65 of 106)
- Relevance
  Sort by

Chronic Myeloid Leukemia (CML) Treatment Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Multiple Myeloma Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Anaphylaxis Treatment Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

US Cell & Gene Therapy Market - Focused Insights 2023-2028

 Report
May 2023
United States

From

€1481EUR$1,500USD£1,233GBP

Germany Cell and Gene Therapy Market - Focused Insights 2023-2028

 Report
March 2023
Germany

From

€1481EUR$1,500USD£1,233GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Erythropoietin Drugs Market Report by Drug Class, Product Type, Application, End-User, and Region 2024-2032

 Report
August 2024
140 Pages
Global

From

€3851EUR$3,899USD£3,204GBP

Peptide Therapeutics Market 2024-2028

 Report
June 2024
148 Pages
Global

From

€2469EUR$2,500USD£2,054GBP

Chronic Lymphocytic Leukemia Treatment Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Inflammatory Bowel Disease Treatment Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Protein Therapeutics Market 2024-2028

 Report
May 2024
191 Pages
Global

From

€2469EUR$2,500USD£2,054GBP

Cancer Biomarkers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

 Report
February 2024
120 Pages
Global

From

€4691EUR$4,750USD£3,903GBP

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a Landscape Analysis of Technologies, Targets, Business and Financing from An Industry Perspective

 Report
November 2022
418 Pages
Global

From

€2350EUR$2,549USD£2,024GBP

Pharma R&D Outsourcing Market - Global Outlook & Forecast 2022-2027

 Report
September 2022
357 Pages
Global

From

€3704EUR$3,750USD£3,082GBP

Dermatological Drug Market - Forecasts from 2024 to 2029

 Report
April 2024
125 Pages
Global

From

€3901EUR$3,950USD£3,246GBP

Cancer Immunotherapy - Global Strategic Business Report

 Report
November 2024
93 Pages
Global

From

€5531EUR$5,600USD£4,602GBP

Sarcoma Drugs - Global Strategic Business Report

 Report
November 2024
93 Pages
Global

From

€5531EUR$5,600USD£4,602GBP

Multiple Myeloma Market - Growth, Trends, and Forecasts (2023-2028)

 Report
April 2023
111 Pages
Global

From

€4691EUR$4,750USD£3,903GBP

Combination Antibody Therapy - Global Strategic Business Report

 Report
November 2024
196 Pages
Global

From

€4889EUR$4,950USD£4,068GBP

Immunotherapy Drugs - Global Strategic Business Report

 Report
November 2024
193 Pages
Global

From

€4889EUR$4,950USD£4,068GBP

Metastatic Bone Disease - Global Strategic Business Report

 Report
November 2024
194 Pages
Global

From

€4889EUR$4,950USD£4,068GBP

2,101 Results (Page 65 of 106)
- 1
- 63
- 64
- 65
- 66
- 67

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.